Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
6/2023 ceased to operate
PRiiMO
PRiiMO Overview
PRiiMO has developed a digital platform for patients and their physicians that uses an AI-based precision medicine engine to personalize cancer treatment plans.
The platform's data analytics and actionable insights are based on an intelligent combination of diverse data sources drawn from medical records, labs, genomics, imaging, pathology, biometrics, and patient behavior.
PRiiMO has selected prostate cancer as its first disease domain, serving urologists and their patients while building a comprehensive multi-source data asset for prostate cancer.
PRiiMO's mission is to personalize the prevention, screening, diagnosis, monitoring, treatment, and post-treatment for patients, minimizing risk and treatment costs and maximizing the number of normal life years.